What we measure: Number of Gavi vaccine markets where supply of appropriate vaccines is both sufficient and uninterrupted to meet demand.
What we measure: The weighted average vaccine price of fully immunising a child with pentavalent, pneumococcal and rotavirus vaccines.
What we measure: Number of vaccines and other related products with improved characteristics procured compared with the baseline year.
What we measure: Number of Gavi vaccine markets classified as benefiting from high or moderate health. Each vaccine market is rated as having high, moderate or low market health, or as having no healthy market dynamics.